China Resources Boya Bio-pharmaceutical Group Co., Ltd. (300294.SZ)
CNY 27.5
(-0.11%)
CNY 27.5
(-0.11%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | 2.63 Billion CNY | -4.6% |
| 2022 | 2.75 Billion CNY | 4.08% |
| 2021 | 2.65 Billion CNY | 5.47% |
| 2020 | 2.51 Billion CNY | -8.98% |
| 2019 | 2.76 Billion CNY | 15.64% |
| 2018 | 2.38 Billion CNY | 63.47% |
| 2017 | 1.46 Billion CNY | 54.29% |
| 2016 | 946.59 Million CNY | 74.27% |
| 2015 | 543.18 Million CNY | 24.07% |
| 2014 | 437.79 Million CNY | 78.49% |
| 2013 | 245.27 Million CNY | 7.93% |
| 2012 | 227.25 Million CNY | 15.52% |
| 2011 | 196.72 Million CNY | 38.71% |
| 2010 | 141.82 Million CNY | 18.46% |
| 2009 | 119.72 Million CNY | 32.78% |
| 2008 | 90.16 Million CNY | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q1 | 448.45 Million CNY | -1.91% |
| 2024 Q3 | 349.37 Million CNY | -21.18% |
| 2024 Q2 | 443.27 Million CNY | -1.15% |
| 2023 Q3 | 649.52 Million CNY | -11.62% |
| 2023 Q2 | 734.94 Million CNY | -8.81% |
| 2023 Q1 | 805.92 Million CNY | 19.23% |
| 2023 FY | 2.63 Billion CNY | -4.6% |
| 2023 Q4 | 457.2 Million CNY | -29.61% |
| 2022 Q4 | 675.95 Million CNY | -1.18% |
| 2022 Q1 | 654.63 Million CNY | 2.44% |
| 2022 Q2 | 744.08 Million CNY | 13.66% |
| 2022 FY | 2.75 Billion CNY | 4.08% |
| 2022 Q3 | 684.02 Million CNY | -8.07% |
| 2021 Q1 | 624.11 Million CNY | -4.84% |
| 2021 Q4 | 639.03 Million CNY | -10.83% |
| 2021 Q3 | 716.66 Million CNY | 6.85% |
| 2021 Q2 | 670.71 Million CNY | 7.47% |
| 2021 FY | 2.65 Billion CNY | 5.47% |
| 2020 FY | 2.51 Billion CNY | -8.98% |
| 2020 Q4 | 655.83 Million CNY | -0.77% |
| 2020 Q3 | 660.95 Million CNY | 8.01% |
| 2020 Q2 | 611.92 Million CNY | 0.38% |
| 2020 Q1 | 609.59 Million CNY | -20.69% |
| 2019 Q2 | 697.55 Million CNY | 12.63% |
| 2019 Q4 | 768.64 Million CNY | 5.79% |
| 2019 Q1 | 619.33 Million CNY | -16.28% |
| 2019 FY | 2.76 Billion CNY | 15.64% |
| 2019 Q3 | 726.57 Million CNY | 4.16% |
| 2018 Q2 | 585.48 Million CNY | 22.28% |
| 2018 Q4 | 739.75 Million CNY | 24.47% |
| 2018 FY | 2.38 Billion CNY | 63.47% |
| 2018 Q3 | 594.32 Million CNY | 1.51% |
| 2018 Q1 | 478.79 Million CNY | -22.88% |
| 2017 FY | 1.46 Billion CNY | 54.29% |
| 2017 Q2 | 317.45 Million CNY | 42.37% |
| 2017 Q3 | 299.27 Million CNY | -5.73% |
| 2017 Q1 | 222.97 Million CNY | -23.84% |
| 2017 Q4 | 620.81 Million CNY | 107.44% |
| 2016 FY | 946.59 Million CNY | 74.27% |
| 2016 Q4 | 292.77 Million CNY | 16.11% |
| 2016 Q1 | 176.01 Million CNY | -5.01% |
| 2016 Q2 | 225.65 Million CNY | 28.2% |
| 2016 Q3 | 252.15 Million CNY | 11.75% |
| 2015 Q1 | 103.93 Million CNY | -25.61% |
| 2015 Q3 | 132.71 Million CNY | 9.46% |
| 2015 Q4 | 185.29 Million CNY | 39.62% |
| 2015 Q2 | 121.24 Million CNY | 16.66% |
| 2015 FY | 543.18 Million CNY | 24.07% |
| 2014 Q2 | 100.65 Million CNY | 11.63% |
| 2014 Q1 | 90.16 Million CNY | 32.6% |
| 2014 FY | 437.79 Million CNY | 78.49% |
| 2014 Q4 | 139.71 Million CNY | 30.25% |
| 2014 Q3 | 107.26 Million CNY | 6.57% |
| 2013 Q3 | 62.55 Million CNY | 9.03% |
| 2013 Q4 | 67.99 Million CNY | 8.7% |
| 2013 FY | 245.27 Million CNY | 7.93% |
| 2013 Q1 | 57.35 Million CNY | -2.62% |
| 2013 Q2 | 57.37 Million CNY | 0.03% |
| 2012 FY | 227.25 Million CNY | 15.52% |
| 2012 Q4 | 58.89 Million CNY | -4.21% |
| 2012 Q2 | 53.66 Million CNY | 0.84% |
| 2012 Q3 | 61.48 Million CNY | 14.58% |
| 2012 Q1 | 53.21 Million CNY | 1.79% |
| 2011 Q1 | 42.17 Million CNY | 0.0% |
| 2011 FY | 196.72 Million CNY | 38.71% |
| 2011 Q2 | 54.71 Million CNY | 29.71% |
| 2011 Q3 | 47.55 Million CNY | -13.09% |
| 2011 Q4 | 52.28 Million CNY | 9.94% |
| 2010 FY | 141.82 Million CNY | 18.46% |
| 2009 FY | 119.72 Million CNY | 32.78% |
| 2008 FY | 90.16 Million CNY | 0.0% |